References
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World
Health Organization classification of myeloid neoplasms and acute
leukemia. Blood 2016;127(20):2391-2405.
2 Horny HP, Metcalfe DD, Akin C, et al. Mastocytosis. In: Swerdlow SH et
al., eds. WHO Classification of Tumors of Hematopoietic and Lymphoid
Tissues. Lyon, France: International Agency for Research and Cancer
(IARC); 2017:62-69.
3 Pardanani A. Systemic mastocytosis in adults: 2019 update on
diagnosis, risk stratification and management. Am J Hematol
2019;94(3):363-377.
4 Scherber RM, Borate U. How we diagnose and treat systemic mastocytosis
in adults. Br J Haematol 2018;180(1):11-23.
5 Lim KH, Tefferi A, Lasho TL, et al. Systemic mastocytosis in 342
consecutive adults: survival studies and prognostic factors. Blood 2009;
113:5727-5736.
6 Lim KH, Pardanani A, Butterfield JH, Li CY, Tefferi A. Cytoreductive
therapy in 108 adults with systemic mastocytosis: outcome analysis and
response prediction during treatment with interferon-alpha, hydroxyurea,
imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol
2009;84:790-794.
7 Barete S, Lortholary O, Damaj G, et al. Long-term efficacy and safety
of cladribine (2-CdA) in adult patients with mastocytosis. Blood
2015;126:1009-1016.
8 Ustun C, Gotlib J, Popat U, et al. Consensus opinion on allogeneic
hematopoietic cell transplantation in advanced systemic mastocytosis.
Biol Blood Marrow Transplant 2016;22:1348-1356.
9 Chandesris MO, Damaj G, Canioni D, et al. Midostaurin in advanced
systemic mastocytosis. N Engl J Med 2016;374(26):2605-2607.
10 Escribano L, Alvarez-Twose I, Sánchez-Muñoz L, et al. Prognosis in
adult indolent systemic mastocytosis: A long-term study of the Spanish
Network on Mastocytosis in a series of 145 patients. J Allergy Clin
Immunol 2009; 124, 514–521.
11
Gotlib
J, Pardanani
A, Akin C, et al. International Working Group-Myeloproliferative
Neoplasms Research and Treatment (IWG-MRT) & European Competence
Network on Mastocytosis (ECNM) consensus response criteria in advanced
systemic mastocytosis.
Blood 2013;
121(13):2393-401.